AMIA comments to ONC on Personal Health Records
AMIA comments to ONC on consumer’s privacy and security of Personal Health Records. AMIA discusses the benefits and risks to consumers of PHRs and other points.
AMIA comments to ONC on consumer’s privacy and security of Personal Health Records. AMIA discusses the benefits and risks to consumers of PHRs and other points.
AMIA’s testimony examines patient data matching before ONC’s Privacy & Security Tiger Team. AMIA's Brad Malin discusses some concerns of the accuracy in patient matching and the implications of misidentified data in patient care and biomedical research, which could lead to false match or false non-match.
AMIA submitted comments to HHS on the Common Format, Device or Medical/Surgical Supply, including HIT Devices. The comments address patient safety data collections and event reporting. Failures with HIT devices are different from those associated with other devices and warrant a distinct form and classification for reporting failures. AMIA submits […]
The current commercial health information technology (IT) arena encompasses a number of competing firms that provide electronic health applications to hospitals, clinical practices, and other healthcare-related entities. Such applications collect, store, and analyze patient information. Some vendors incorporate contract language whereby purchasers of health IT systems, such as hospitals and […]
AMIA comments on the HHS NPRM to modify HIPPA Privacy, Security and Enforcement Rules under the Health Information Technology for Economic and Clinical Act (HITECH) published in the Federal Register on July 14, 2010. The discussion focuses mainly on protecting the PHI of consumers by the way of business associates […]
AMIA comments to DEA on E-Prescribing Controlled Substances which would revise the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Controlled Substances Act, or CSA) and the related regulations to allow healthcare providers to write prescriptions for controlled substances electronically. These revisions would have to allow e-prescribing controlled substances […]
AMIA comments on the proposed establishment of the Certification Programs for health information technology (HIT). AMIA agrees with the distinction between “testing” and “certification,” and support the use of the International Organization for Standard (ISO) and the International Electrotechnical Commission (IEC) ISO/IEC Guides to structure how testing, certification, and accreditation […]
AMIA offers comments to ONC on Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology. AMIA finds absence of detail in the certification criteria and to include directions for testing will ensure that vendor systems integrate standards, specifications, and criteria in ways […]
AMIA comments on the proposed rule which implements the initial stage of incentive funding for meaningful use (MU) of certified EHR technology. AMIA strongly believes that three principles are essential to achieving meaningful use of certified EHR technology: 1) we must invest in people, as well as technology; 2) users […]
AMIA’s testimony to the HIT Policy Committee, Adoption/Certification Workgroup, discusses potential unintended consequences of health information technology (HIT) and HIT policy, as well as effective options for addressing them. AMIA and its task force offer several recommendations that involve unintended consequences and conjure questions from previous observations in identifying safety […]